Firms Consult FDA, Add “Do Not Use” For Under 4 To Pediatric Cold Products
This article was originally published in The Tan Sheet
Executive Summary
Over-the-counter pediatric cough/cold products relabeled "do not use" for children under 4 will reach shelves in the next few weeks in a voluntary program manufacturers coordinated with FDA
You may also be interested in...
FDA Urged To Change OTC Monograph System, But Not In Midstream
“Moving away from the monograph system when we are so close to the end” would “risk setting back the OTC drug review many years or even decades,” CHPA head Scott Melville says at an FDA public hearing. Other stakeholder s explain how the monograph system has failed industry and consumers.
FDA Urged To Change OTC Monograph System, But Not In Midstream
“Moving away from the monograph system when we are so close to the end” would “risk setting back the OTC drug review many years or even decades,” CHPA head Scott Melville says at an FDA public hearing. Other stakeholder s explain how the monograph system has failed industry and consumers.
House Appropriators Push For Revised Pediatric Cough/Cold Labels
House appropriators want FDA to propose by Dec. 31 revised labeling for OTC pediatric cough and cold products that addresses safety and efficacy concerns.